Rapid response to autoimmune hepatitis treatment linked to better outcomes

Patients with autoimmune hepatitis who had a rapid response after treatment were the most likely to achieve normalization of transaminase levels in the following year and had a lower risk for liver-related death or transplantation, according to results of a retrospective study.“Autoimmune hepatitis (AIH) is a rare, chronic liver disease that is characterized by elevated serum transaminases and immunoglobulin G (IgG), inflammatory liver histology and presence of circulating auto antibodies,” Simon Pape, PhD student from the Radboud University Medical in the Netherlands, andRead More

Share on facebook
Share on twitter
Share on linkedin